Trevi Therapeutics, Inc. (TRVI) has 55 open-market insider trades by 27 insiders since 2019. The most active filer is Jennifer L. Good, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mohamad Makhzoumi | 10% Owner | — | 3 | $38.6M | 2022-04-11 |
| Carmen Chang | 10% Owner | — | 3 | $38.6M | 2022-04-11 |
| Paul Edward Walker | 10% Owner | — | 3 | $38.6M | 2022-04-11 |
| Ali Behbahani | 10% Owner | — | 3 | $38.6M | 2022-04-11 |
| Peter W. Sonsini | 10% Owner | — | 3 | $38.6M | 2022-04-11 |
| Scott D. Sandell | 10% Owner | — | 3 | $38.6M | 2022-04-11 |
| Anthony A. Florence Jr. | 10% Owner | — | 3 | $38.6M | 2022-04-11 |
| Forest Baskett | 10% Owner | — | 3 | $35.0M | 2022-04-11 |
| Joshua Makower | 10% Owner | — | 2 | $25.0M | 2020-04-03 |
| David M. Mott | 10% Owner | — | 1 | $25.0M | 2019-05-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael Thomas Heffernan | Director | Sell | $594K | 2026-09-15 |
| Thomas Sciascia | Chief Scientific Officer | Sell | $17K | 2025-03-25 |
| Jennifer L. Good | President | Sell | $35K | 2025-03-21 |
| Farrell Simon | CCO | Sell | $1.1M | 2025-03-10 |
| Jennifer L. Good | President | Sell | $18K | 2024-09-06 |
| Jennifer L. Good | CEO & President | Sell | $295K |
Companies that share insiders with TRVI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-09-03 |
| David P. Meeker | Director | Sell | $13K | 2024-08-27 |
| Thomas Sciascia | Chief Scientific Officer | Sell | $49K | 2024-08-19 |
| Thomas Sciascia | CSO | Sell | $139K | 2024-08-14 |
| Thomas Sciascia | CSO | Sell | $272K | 2024-05-29 |
| Lisa Delfini | CFO | Sell | $11K | 2024-05-22 |
| Jennifer L. Good | CEO & President | Sell | $143K | 2024-05-20 |
| Jennifer L. Good | President | Sell | $13K | 2024-05-10 |
| Lisa Delfini | CFO | Sell | $2K | 2023-10-11 |
| Lisa Delfini | CFO | Sell | $2K | 2023-09-11 |